+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Development and Validation of a Risk Scoring System for Severe Acute Lower Gastrointestinal Bleeding



Development and Validation of a Risk Scoring System for Severe Acute Lower Gastrointestinal Bleeding



Clinical Gastroenterology and Hepatology 14(11): 1562-1570.E2



We aimed to develop and validate a risk scoring system to determine the risk of severe lower gastrointestinal bleeding (LGIB) and predict patient outcomes. We first performed a retrospective analysis of data from 439 patients emergently hospitalized for acute LGIB at the National Center for Global Health and Medicine in Japan, from January 2009 through December 2013. We used data on comorbidities, medication, presenting symptoms, and vital signs, and laboratory test results to develop a scoring system for severe LGIB (defined as continuous and/or recurrent bleeding). We validated the risk score in a prospective study of 161 patients with acute LGIB admitted to the same center from April 2014 through April 2015. We assessed the system's accuracy in predicting patient outcome using area under the receiver operating characteristics curve (AUC) analysis. All patients underwent colonoscopy. In the first study, 29% of the patients developed severe LGIB. We devised a risk scoring system based on nonsteroidal anti-inflammatory drugs use, no diarrhea, no abdominal tenderness, blood pressure of 100 mm Hg or lower, antiplatelet drugs use, albumin level less than 3.0 g/dL, disease scores of 2 or higher, and syncope (NOBLADS), which all were independent correlates of severe LGIB. Severe LGIB developed in 75.7% of patients with scores of 5 or higher compared with 2% of patients without any of the factors correlated with severe LGIB (P < .001). The NOBLADS score determined the severity of LGIB with an AUC value of 0.77. In the validation (second) study, severe LGIB developed in 35% of patients; the NOBLADS score predicted the severity of LGIB with an AUC value of 0.76. Higher NOBLADS scores were associated with a requirement for blood transfusion, longer hospital stay, and intervention (P < .05 for trend). We developed and validated a scoring system for risk of severe LGIB based on 8 factors (NOBLADS score). The system also determined the risk for blood transfusion, longer hospital stay, and intervention. It might be used in decision making regarding intervention and management.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057596017

Download citation: RISBibTeXText

PMID: 27311620

DOI: 10.1016/j.cgh.2016.05.042


Related references

External validation of the NOBLADS score, a risk scoring system for severe acute lower gastrointestinal bleeding. Plos One 13(4): E0196514, 2018

Development, Validation, and Comparative Assessment of an International Scoring System to Determine Risk of Upper Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology 2018, 2018

Su1920 Validation of the Risk Scoring System AIMS65 for Patients With Acute Nonvariceal Upper Gastrointestinal Bleeding in Japan. Gastroenterology 144(5): S-509-S-510, 2013

Development and Validation of a Scoring System That Includes Corrected QT Interval For Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology 2018, 2018

Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut 44(3): 331-335, 1999

Development and validation of a new scoring system to determine the necessity of small-bowel endoscopy in obscure gastrointestinal bleeding. Digestive and Liver Disease 49(11): 1218-1224, 2017

Development and internal validation of a risk scoring system for gastrointestinal events requiring surgery in gastrointestinal lymphoma patients. Journal of Gastroenterology and Hepatology 2018, 2018

Severe acute lower gastrointestinal bleeding: risk factors for morbidity and mortality. Langenbeck's Archives of Surgery 392(2): 165-171, 2006

PTU-035Development and Initial Validation of Prognostic Scoring Systems for lower Gastrointestinal Bleeding. Gut 62(Suppl 1): A57.1-A57, 2013

Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn's disease. Digestive and Liver Disease 44(9): 723-728, 2013

Derivation and validation of a novel risk score for safe discharge after acute lower gastrointestinal bleeding: a modelling study. Lancet. Gastroenterology and Hepatology 2(9): 635-643, 2017

Analysis of risk factors and development of scoring system to predict severity of upper gastrointestinal bleeding in children. Journal of Gastroenterology and Hepatology 2018, 2018

Acute upper gastrointestinal bleeding in childhood: development of the Sheffield scoring system to predict need for endoscopic therapy. Journal of Pediatric Gastroenterology and Nutrition 60(5): 632-636, 2016

A New Scoring System to Predict Poor Clinical Outcomes in Acute Nonvariceal Upper Gastrointestinal Bleeding Patients with High-Risk Stigmata. Gastroenterology Research and Practice 2018: 5032657, 2018

External validation of scoring systems in risk stratification of upper gastrointestinal bleeding. Indian Journal of Gastroenterology 36(2): 105-112, 2017